References
- Beisswenger PJ, Howell SK, O'Dell RM, Wood ME, Touchette AD, Szwergold BS. 2001. α-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care. 24:726–732.
- Cheng YB, Chang MT, Lo YW, Ho CJ, Kuo YC, Chien CT, Chen SY, Liou SS, Kuo YH, Shen YC. 2009. Oxygenated lignans from the fruits of Schisandra arisanensis. J Nat Prod. 72:1663–1668.
- Hooker JD. 1875. Flora of British India. Vol I. London: L. Reeves; 44pp
- Ikeya Y, Sugama K, Tanaka M, Wakamatsu T, Ono H, Takeda S, Oyama T, Maruno M. 1995. Structure determination of billiary metabolites of schizandrin in rat and dog. Chem Pharm Bull. 43:121–129.
- Matcha K, Ghosh S. 2010. An asymmetric route to total synthesis of the furano lignan (+)-veraguensin. Tetrahedr Lett. 51:6924–6927.
- Meerwaldt R, Links L, Zeebregts C, Tio R, Hillebrands J, Smit A. 2008. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol. 7:29.
- Opletal S, Sovava H, Bartlova M. 2004. DiBenzo [a, c] cyclooctadiene lignans of the genus Schisandra importance, isolation and determination. J Chromatogr B. 812:357–371.
- Sadhu SK, Okuyama E, Fujimoto H, ishibashi M. 2003. Separation of Leucas aspera, a medicinal plant of bangladesh, guided by prostaglandin inhibitory and antioxidant activities. Chem Pharm Bull. 51:595–598.
- Stirban A, Negrean M, Starmann B, Gawlowski T, Horstmann T, Gotting C, Kleesiek K, Muller-Roesel M, Koschinsky T, Uribarri J, et al. 2006. Benfotiamine prevents macro and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2. Diabetes Care. 29:2064–2071.
- Striban A, Tschoepe D, Stratmann B. 2009. Shifting the disease management paradigm from glucose: what are the pros. Diabetes Care. 32:S349–S352.
- Suresh G, Tiwari AK, Murthy MRK, Kumar DA, Prasad KRP, Rao RR, Zehra A, Babu KS. 2012. New advanced glycation end-products inhibitors from Dichrostachys cinerea Wight & Arn. J Nat Med. 66:213–216.
- Takahashi K, Takani M. 1975. Studies on constituents of medicinal plants. XIV. constituents of Schizandra nigra Max. Chem Pharm Bull. 23:538–542.
- Talapatra B, Basak A, Talapatra SK. 1982. Terpenoids & related compounds: Part XXII- schizandraflorin, a new tetracyclic tripene dione from Schizandra grandiflora Hook & Thom. Indian J Chem. 21B:76–78.
- Tsai WJ, Shen CC, Tsai TH, Lin LC. 2014. Lignans from the aerial parts of Saururus chinensis: isolation, structural characterization, and their effects on platelet aggregation. J Nat Prod. 77:125 − 131.
- Woo WS, Shin KH, Wagner H, lottert H. 1987. The structure of macelignan from Myristica Fragrans. Phytochemistry. 26:1542–1543.
- Yamasaki K, Hishiki R, Kato E, Kawabata J. 2011. Study of kaempferol glycoside as an insulin mimic reveals glycon to be the key active structure. ACS Med Chem Lett. 2:17–21.
- Yue JM, Xu-Jun, Chen YZ. 1994. Triterpenoids of Schisandra sphennthera. Phytochemistry. 35:1068–1069.